151 related articles for article (PubMed ID: 23177278)
1. Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.
Takahashi Y; Ishii G; Aokage K; Hishida T; Yoshida J; Nagai K
Lung Cancer; 2013 Feb; 79(2):118-24. PubMed ID: 23177278
[TBL] [Abstract][Full Text] [Related]
2. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
3. The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.
Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
Eur J Cardiothorac Surg; 2011 May; 39(5):763-8. PubMed ID: 20864350
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
6. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma.
Takuwa T; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Neri S; Hasegawa S; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3943-52. PubMed ID: 22669454
[TBL] [Abstract][Full Text] [Related]
7. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
[TBL] [Abstract][Full Text] [Related]
8. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.
Xu L; Tavora F; Burke A
Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071
[TBL] [Abstract][Full Text] [Related]
9. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
11. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
13. Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2012 Nov; 78(2):153-60. PubMed ID: 22944144
[TBL] [Abstract][Full Text] [Related]
14. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
15. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung.
Kato F; Hamasaki M; Miyake Y; Iwasaki A; Iwasaki H; Nabeshima K
Lung Cancer; 2012 Sep; 77(3):495-500. PubMed ID: 22727683
[TBL] [Abstract][Full Text] [Related]
17. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
19. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
